CrescNet - Growth Monitoring Network
Launched by UNIVERSITY OF LEIPZIG · Mar 1, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The CrescNet - Growth Monitoring Network is a study designed to help doctors better identify growth problems in children and adolescents, particularly those related to obesity and growth disorders. This trial involves a large group of healthcare providers, including primary care doctors and pediatric specialists, who will work together to gather important information about children's growth patterns. By collecting this data, the study aims to improve the early detection of growth issues, allowing for timely interventions and support.
Anyone from the community who visits a doctor or pediatrician, whether for routine check-ups or specific health concerns, can potentially participate in this trial. There are no specific exclusion criteria, meaning that all children and adolescents are welcome to join. Participants can expect to contribute to important research that could lead to better growth monitoring practices in the future. It's a great opportunity to be part of something that may help improve the health and development of children in the community.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Population based sample with inclusion of any patient seen by primary care or institutional physician/pediatrician, regardless of the objective for the visit (well child visits, acute visits or special requests)
- • Exclusion Criteria: none
About University Of Leipzig
The University of Leipzig is a renowned academic institution in Germany, recognized for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials that aim to enhance patient care and contribute to the understanding of various health conditions. Its research initiatives are supported by state-of-the-art facilities and a diverse team of experts, positioning the University of Leipzig as a leader in the field of clinical research and a vital contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leipzig, Saxony, Germany
Patients applied
Trial Officials
Roland W Pfäffle, MD
Principal Investigator
University of Leipzig
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials